UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000009256
Receipt number R000010868
Scientific Title A phase 1 study of cisplatin/pemetrexed/crizotinib followed by maintenance crizotinib in patients with stage 3B or 4 EML4-ALK positive non-small-cell lung cancer.
Date of disclosure of the study information 2012/11/05
Last modified on 2012/11/03 19:25:43

No. Disposal Last modified on Item of update
1 Insert 2012/11/03 19:26:03